Home » Stocks » INTI

Inhibitor Therapeutics, Inc. (INTI)

Stock Price: $0.0750 USD 0.0000 (0.00%)
Updated May 7, 2021 9:30 AM EDT - Market closed
Market Cap 28.19M
Revenue (ttm) n/a
Net Income (ttm) -1.26M
Shares Out 371.93M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $0.0750
Previous Close $0.0750
Change ($) 0.0000
Change (%) 0.00%
Day's Open 0.0750
Day's Range 0.0750 - 0.0750
Day's Volume 0
52-Week Range 0.0300 - 0.1500

News

There are no news available yet.

About INTI

Inhibitor Therapeutics, Inc., a pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States. It engages in the development of therapies for prostate and lung cancer utilizing SUBA-Itraconazole, an oral formulation of the drug itraconazole; and conducted a positive Phase 2b study of SUBA-Itraconazole for the treatment of basal cell carcinoma nevus syndrome. The company was formerly known as HedgePath Pharmaceuticals, Inc. and changed... [Read more...]

Industry
Biotechnology
Founded
1992
CEO
Nicholas Virca
Employees
1
Stock Exchange
OTCMKTS
Ticker Symbol
INTI
Full Company Profile

Financial Performance

Financial Statements